10-Q Filing

ELI LILLY & CO CIK: 59478 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0000059478-22-000196`
Period End Date	20220630
Filing Date	20220804
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	lly-20220630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 60 Cash Flow Statement 62 Stockholders Equity 10 Comprehensive Income 12

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Allowances for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$19.20M	USD	Point-in-time
Allowances for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$22.50M	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$10.12B	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$9.98B	USD	Point-in-time
Cash and cash equivalents (Note 6)	`CashAndCashEquivalentsAtCarryingValue`	$2.62B	USD	Point-in-time
Cash and cash equivalents (Note 6)	`CashAndCashEquivalentsAtCarryingValue`	$3.82B	USD	Point-in-time
Short-term investments (Note 6)	`ShortTermInvestments`	$113.80M	USD	Point-in-time
Short-term investments (Note 6)	`ShortTermInvestments`	$90.10M	USD	Point-in-time
Accounts receivable, net of allowances of $19.2 (2022) and $22.5 (2021)	`AccountsReceivableNetCurrent`	$6.36B	USD	Point-in-time
Accounts receivable, net of allowances of $19.2 (2022) and $22.5 (2021)	`AccountsReceivableNetCurrent`	$6.67B	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$1.45B	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$1.31B	USD	Point-in-time
Inventories	`InventoryNet`	$3.90B	USD	Point-in-time
Inventories	`InventoryNet`	$3.89B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseCurrent`	$2.53B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseCurrent`	$2.81B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$18.45B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$17.12B	USD	Point-in-time
Investments (Note 6)	`LongTermInvestments`	$3.21B	USD	Point-in-time
Investments (Note 6)	`LongTermInvestments`	$2.59B	USD	Point-in-time
Goodwill	`Goodwill`	$3.89B	USD	Point-in-time
Goodwill	`Goodwill`	$3.89B	USD	Point-in-time
Other intangibles, net	`IntangibleAssetsNetExcludingGoodwill`	$7.69B	USD	Point-in-time
Other intangibles, net	`IntangibleAssetsNetExcludingGoodwill`	$7.50B	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$2.49B	USD	Point-in-time
Deferred tax assets	`DeferredIncomeTaxAssetsNet`	$2.37B	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $10,119.7 (2022) and $9,976.7 (2021)	`PropertyPlantAndEquipmentNet`	$9.13B	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $10,119.7 (2022) and $9,976.7 (2021)	`PropertyPlantAndEquipmentNet`	$8.99B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$4.08B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$4.47B	USD	Point-in-time
Total assets	`Assets`	$47.06B	USD	Point-in-time
Total assets	`Assets`	$48.81B	USD	Point-in-time
Short-term borrowings and current maturities of long-term debt	`DebtCurrent`	$1.54B	USD	Point-in-time
Short-term borrowings and current maturities of long-term debt	`DebtCurrent`	$2.12B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.66B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.67B	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$958.10M	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$835.80M	USD	Point-in-time
Sales rebates and discounts	`SalesRebatesAndDiscounts`	$7.99B	USD	Point-in-time
Sales rebates and discounts	`SalesRebatesAndDiscounts`	$6.85B	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$885.50M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$882.20M	USD	Point-in-time
Income taxes payable	`TaxesPayableCurrent`	$126.60M	USD	Point-in-time
Income taxes payable	`TaxesPayableCurrent`	$126.90M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$2.00B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$3.03B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.62B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.05B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$15.35B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$14.69B	USD	Point-in-time
Accrued retirement benefits (Note 8)	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$1.89B	USD	Point-in-time
Accrued retirement benefits (Note 8)	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$1.95B	USD	Point-in-time
Long-term income taxes payable	`AccruedIncomeTaxesNoncurrent`	$3.56B	USD	Point-in-time
Long-term income taxes payable	`AccruedIncomeTaxesNoncurrent`	$3.92B	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$1.73B	USD	Point-in-time
Deferred tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$862.50M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$1.78B	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$1.64B	USD	Point-in-time
Total other liabilities	`LiabilitiesNoncurrent`	$24.60B	USD	Point-in-time
Total other liabilities	`LiabilitiesNoncurrent`	$22.78B	USD	Point-in-time
Commitments and Contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock	`CommonStockValue`	$596.30M	USD	Point-in-time
Common stock	`CommonStockValue`	$594.10M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$6.83B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$6.75B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$8.96B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$8.56B	USD	Point-in-time
Employee benefit trust	`CommonStockSharesHeldInEmployeeTrust`	$3.01B	USD	Point-in-time
Employee benefit trust	`CommonStockSharesHeldInEmployeeTrust`	$3.01B	USD	Point-in-time
Accumulated other comprehensive loss (Note 10)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-4.29B	USD	Point-in-time
Accumulated other comprehensive loss (Note 10)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-4.34B	USD	Point-in-time
Cost of common stock in treasury	`TreasuryStockCommonValue`	$52.70M	USD	Point-in-time
Cost of common stock in treasury	`TreasuryStockCommonValue`	$50.50M	USD	Point-in-time
Total Eli Lilly and Company shareholders' equity	`StockholdersEquity`	$8.98B	USD	Point-in-time
Total Eli Lilly and Company shareholders' equity	`StockholdersEquity`	$8.54B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$175.60M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$114.50M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.66B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.15B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$48.81B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$47.06B	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Revenue (Note 2)	`Revenues`	$13.55B	USD	2 Qtrs
Revenue (Note 2)	`Revenues`	$6.49B	USD	1 Quarter
Revenue (Note 2)	`Revenues`	$6.74B	USD	1 Quarter
Revenue (Note 2)	`Revenues`	$14.30B	USD	2 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$1.43B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$3.50B	USD	2 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$1.95B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$3.83B	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.78B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.33B	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.66B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.39B	USD	2 Qtrs
Marketing, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$3.18B	USD	2 Qtrs
Marketing, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$3.26B	USD	2 Qtrs
Marketing, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$1.69B	USD	1 Quarter
Marketing, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$1.63B	USD	1 Quarter
Acquired in-process research and development and development milestones (Note 3)	`AcquiredInProcessResearchAndDevelopmentAndDevelopmentMilestones`	$42.80M	USD	1 Quarter
Acquired in-process research and development and development milestones (Note 3)	`AcquiredInProcessResearchAndDevelopmentAndDevelopmentMilestones`	$354.80M	USD	2 Qtrs
Acquired in-process research and development and development milestones (Note 3)	`AcquiredInProcessResearchAndDevelopmentAndDevelopmentMilestones`	$440.40M	USD	1 Quarter
Acquired in-process research and development and development milestones (Note 3)	`AcquiredInProcessResearchAndDevelopmentAndDevelopmentMilestones`	$606.00M	USD	2 Qtrs
Asset impairment, restructuring, and other special charges (Note 5)	`RestructuringSettlementAndImpairmentProvisions`	-	USD	2 Qtrs
Asset impairment, restructuring, and other special charges (Note 5)	`RestructuringSettlementAndImpairmentProvisions`	-	USD	1 Quarter
Asset impairment, restructuring, and other special charges (Note 5)	`RestructuringSettlementAndImpairmentProvisions`	$211.60M	USD	2 Qtrs
Asset impairment, restructuring, and other special charges (Note 5)	`RestructuringSettlementAndImpairmentProvisions`	-	USD	1 Quarter
Othernet, (income) expense (Note 11)	`NonoperatingIncomeExpense`	$511.60M	USD	2 Qtrs
Othernet, (income) expense (Note 11)	`NonoperatingIncomeExpense`	$190.50M	USD	1 Quarter
Othernet, (income) expense (Note 11)	`NonoperatingIncomeExpense`	$-119.20M	USD	1 Quarter
Othernet, (income) expense (Note 11)	`NonoperatingIncomeExpense`	$-469.90M	USD	2 Qtrs
Costs, expenses, and other	`CostOfSalesOperatingExpensesAndOtherNet`	$11.15B	USD	2 Qtrs
Costs, expenses, and other	`CostOfSalesOperatingExpensesAndOtherNet`	$5.15B	USD	1 Quarter
Costs, expenses, and other	`CostOfSalesOperatingExpensesAndOtherNet`	$5.40B	USD	1 Quarter
Costs, expenses, and other	`CostOfSalesOperatingExpensesAndOtherNet`	$10.48B	USD	2 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.07B	USD	2 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.59B	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.09B	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.14B	USD	2 Qtrs
Income taxes (Note 7)	`IncomeTaxExpenseBenefit`	$203.70M	USD	1 Quarter
Income taxes (Note 7)	`IncomeTaxExpenseBenefit`	$289.10M	USD	2 Qtrs
Income taxes (Note 7)	`IncomeTaxExpenseBenefit`	$138.40M	USD	1 Quarter
Income taxes (Note 7)	`IncomeTaxExpenseBenefit`	$324.80M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$952.50M	USD	1 Quarter
Net income	`NetIncomeLoss`	$1.39B	USD	1 Quarter
Net income	`NetIncomeLoss`	$2.75B	USD	2 Qtrs
Net income	`NetIncomeLoss`	$2.86B	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.06	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.17	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.53	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.02	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.16	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.05	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.01	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.53	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	900.30M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	908.20M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	907.30M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	902.00M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	902.90M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	910.40M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	911.60M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	904.40M	shares	2 Qtrs

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$952.50M	USD	1 Quarter
Net income	`NetIncomeLoss`	$1.39B	USD	1 Quarter
Net income	`NetIncomeLoss`	$2.75B	USD	2 Qtrs
Net income	`NetIncomeLoss`	$2.86B	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$784.60M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$719.60M	USD	2 Qtrs
Change in deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$413.80M	USD	2 Qtrs
Change in deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$1.12B	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$193.10M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$177.40M	USD	2 Qtrs
Net investment (gains) losses	`GainLossOnInvestments`	$-545.60M	USD	2 Qtrs
Net investment (gains) losses	`GainLossOnInvestments`	$518.10M	USD	2 Qtrs
Acquired in-process research and development	`AcquiredInProcessResearchAndDevelopment`	$324.30M	USD	2 Qtrs
Acquired in-process research and development	`AcquiredInProcessResearchAndDevelopment`	$233.00M	USD	2 Qtrs
Other changes in operating assets and liabilities, net of acquisitions and divestitures	`IncreaseDecreaseInOtherOperatingCapitalNet`	$117.60M	USD	2 Qtrs
Other changes in operating assets and liabilities, net of acquisitions and divestitures	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-118.40M	USD	2 Qtrs
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$-49.20M	USD	2 Qtrs
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$319.60M	USD	2 Qtrs
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$3.32B	USD	2 Qtrs
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$3.47B	USD	2 Qtrs
Net purchases of property and equipment	`PaymentsToAcquireProductiveAssets`	$681.60M	USD	2 Qtrs
Net purchases of property and equipment	`PaymentsToAcquireProductiveAssets`	$736.40M	USD	2 Qtrs
Proceeds from sales and maturities of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$57.60M	USD	2 Qtrs
Proceeds from sales and maturities of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$21.30M	USD	2 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$32.90M	USD	2 Qtrs
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$26.60M	USD	2 Qtrs
Proceeds from sales of noncurrent investments	`ProceedsFromSaleOfLongtermInvestments`	$168.50M	USD	2 Qtrs
Proceeds from sales of noncurrent investments	`ProceedsFromSaleOfLongtermInvestments`	$461.90M	USD	2 Qtrs
Purchases of noncurrent investments	`PaymentsToAcquireLongtermInvestments`	$251.40M	USD	2 Qtrs
Purchases of noncurrent investments	`PaymentsToAcquireLongtermInvestments`	$503.10M	USD	2 Qtrs
Cash paid for acquisitions, net of cash acquired (Note 3)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$747.40M	USD	2 Qtrs
Cash paid for acquisitions, net of cash acquired (Note 3)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Purchases of in-process research and development	`PurchasedInProcessResearchAndDevelopment`	$341.80M	USD	2 Qtrs
Purchases of in-process research and development	`PurchasedInProcessResearchAndDevelopment`	$571.80M	USD	2 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-50.50M	USD	2 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$111.30M	USD	2 Qtrs
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.77B	USD	2 Qtrs
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.48B	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$1.77B	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$1.54B	USD	2 Qtrs
Net change in short-term borrowings	`ProceedsFromShortTermDebt`	$2.12B	USD	2 Qtrs
Net change in short-term borrowings	`ProceedsFromShortTermDebt`	$196.30M	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.56B	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	-	USD	2 Qtrs
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$500.00M	USD	2 Qtrs
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$1.50B	USD	2 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-294.80M	USD	2 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-290.00M	USD	2 Qtrs
Net Cash Used for Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.14B	USD	2 Qtrs
Net Cash Used for Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-3.00B	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-1.60M	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-35.80M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.20B	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-437.10M	USD	2 Qtrs
Cash and cash equivalents at January 1	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.66B	USD	Point-in-time
Cash and cash equivalents at January 1	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.22B	USD	Point-in-time
Cash and cash equivalents at January 1	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.62B	USD	Point-in-time
Cash and cash equivalents at January 1	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.82B	USD	Point-in-time
Cash and Cash Equivalents at June 30	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.66B	USD	Point-in-time
Cash and Cash Equivalents at June 30	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.22B	USD	Point-in-time
Cash and Cash Equivalents at June 30	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.62B	USD	Point-in-time
Cash and Cash Equivalents at June 30	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.82B	USD	Point-in-time

Stockholders Equity 10 line items

Line Item	Tag	Value	Unit	Period
Cash dividend declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.70	USD	1 Quarter
Cash dividend declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.96	USD	1 Quarter
Cash dividend declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.96	USD	2 Qtrs
Cash dividend declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.70	USD	2 Qtrs
Stock repurchase program, remaining authorized amount	`StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1`	$3.25B	USD	Point-in-time
Stock repurchase program, authorized amount	`StockRepurchaseProgramAuthorizedAmount1`	$5.00B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.66B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.15B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.66B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.15B	USD	Point-in-time

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$952.50M	USD	1 Quarter
Net income	`NetIncomeLoss`	$1.39B	USD	1 Quarter
Net income	`NetIncomeLoss`	$2.75B	USD	2 Qtrs
Net income	`NetIncomeLoss`	$2.86B	USD	2 Qtrs
Other comprehensive income (loss), net of tax (Note 10)	`OtherComprehensiveIncomeLossNetOfTax`	$108.50M	USD	1 Quarter
Other comprehensive income (loss), net of tax (Note 10)	`OtherComprehensiveIncomeLossNetOfTax`	$55.40M	USD	2 Qtrs
Other comprehensive income (loss), net of tax (Note 10)	`OtherComprehensiveIncomeLossNetOfTax`	$-62.40M	USD	1 Quarter
Other comprehensive income (loss), net of tax (Note 10)	`OtherComprehensiveIncomeLossNetOfTax`	$209.30M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$1.50B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$2.91B	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$890.10M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$2.95B	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.